Boasting a new cell culture room and expanded instrumentation to accommodate in-vitro testing, these expanded metabolism capabilities will provide clients with the ability to overcome limitations that come with animal and human models of metabolism testing.
Additionally, the augmented service offers more comprehensive profiles for faster regulatory agencies’ approvals, quicker decisions on test compounds for safety and stability, and identification of human-specific metabolites to predict unique metabolites, disproportionate metabolites, and/or bioavailability to select candidates with desirable profiles.